Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. United States Hereditary Genetic Testing Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Technique (PCR, DNA Sequencing, Microarrays, Others)
5.2.2. By Application (Cardiology, Oncology, Pharmacogenomics, Cognitive Dysfunction, Pathogenomics, Others)
5.2.3. By Payer (Public Health Insurance, Private Health Insurance, Out of Pocket)
5.2.4. By End User (Hospitals, Independent Laboratories)
5.2.5. By Region
5.2.6. By Company (2022)
5.3. Market Map
5.3.1. By Technique
5.3.2. By Application
5.3.3. By Payer
5.3.4. By End User
5.3.5. By Region
6. North-East United States Hereditary Genetic Testing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Technique
6.2.2. By Application
6.2.3. By Payer
6.2.4. By End User
7. Mid-West United States Hereditary Genetic Testing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technique
7.2.2. By Application
7.2.3. By Payer
7.2.4. By End User
8. West United States Hereditary Genetic Testing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technique
8.2.2. By Application
8.2.3. By Payer
8.2.4. By End User
9. South United States Hereditary Genetic Testing Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Technique
9.2.2. By Application
9.2.3. By Payer
9.2.4. By End User
10. Market Dynamics
10.1. Drivers
8.1.1 Growing Prevalence of Chronic Disorders
8.1.2 Growing Demand for Personalized Medicine
8.1.3 Growing Advancement in Genetic Testing
10.2. Challenges
8.2.1 Clinical issues of DNA test kits
8.2.2 Regulatory challenges pertaining to the use of DTC genetic tests
11. Market Trends & Developments
12. Policy & Regulatory Landscape
13. United States Economic Profile
14. United States Hereditary Genetic Testing: SWOT Analysis
15. Porter’s Five Forces Analysis
15.1. Competition in the Industry
15.2. Potential of New Entrants
15.3. Power of Suppliers
15.4. Power of Customers
15.5. Threat of Substitute Products
16. Competitive Landscape
16.1. Business Overview
16.2. Product Offerings
16.3. Recent Developments
16.4. Financials (As Reported)
16.5. Key Personnel
16.5.1. Invitae Corporation
16.5.2. Ambry Genetics
16.5.3. BioReference Laboratories Inc.
16.5.4. Progenity Inc.
16.5.5. Pathema Gx Lab, LLC
16.5.6. Quest Diagnostics Incorporated
16.5.7. Myriad Genetics Inc.
16.5.8. Fulgent Genetics, Inc.
16.5.9. Burning Rock Biotech Limited.
17. Strategic Recommendations